Monogram Orthopaedics Stock (NASDAQ:MGRM)
Previous Close
$2.51
52W Range
$1.53 - $4.90
50D Avg
$2.31
200D Avg
$2.36
Market Cap
$88.53M
Avg Vol (3M)
$104.97K
Beta
2.47
Div Yield
-
MGRM Company Profile
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.